Invention Grant
US08546399B2 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
有权
凋亡诱导剂用于治疗癌症和免疫和自身免疫性疾病
- Patent Title: Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
- Patent Title (中): 凋亡诱导剂用于治疗癌症和免疫和自身免疫性疾病
-
Application No.: US12787682Application Date: 2010-05-26
-
Publication No.: US08546399B2Publication Date: 2013-10-01
- Inventor: Milan Bruncko , Hong Ding , George A. Doherty , Steven W. Elmore , Lisa A. Hasvold , Laura Hexamer , Aaron R. Kunzer , Xiaohong Song , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Michael D. Wendt , Robert Mantei , Todd M. Hansen
- Applicant: Milan Bruncko , Hong Ding , George A. Doherty , Steven W. Elmore , Lisa A. Hasvold , Laura Hexamer , Aaron R. Kunzer , Xiaohong Song , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Michael D. Wendt , Robert Mantei , Todd M. Hansen
- Applicant Address: US IL North Chicago
- Assignee: Abbvie Inc.
- Current Assignee: Abbvie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Jones Day
- Main IPC: A61K31/407
- IPC: A61K31/407 ; C07D401/12
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Public/Granted literature
- US20100305122A1 APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Public/Granted day:2010-12-02
Information query
IPC分类:
